Hematological diseases, such as chronic myeloid leukemia, myelofibrosis, basophilic leukemia, chronic metastatic cancer and Hodgkin's disease, are often accompanied by an increase in the number of basophils.
Extended data:
In animal experiments, researchers found that only neutrophils can achieve the therapeutic effect of cancer immunotherapy. After injection of therapeutic antibodies, neutrophils contact with antibodies and are activated, thus gaining the ability to kill tumor cells. The researchers observed that immunotherapy could not achieve therapeutic effect in neutropenic mice.
Similarly, neutrophils that are not in contact with antibodies cannot reduce tumors. The researchers confirmed the above observation again in experiments related to skin cancer, indicating that neutrophils play an important role in immunotherapy of various cancers.
Baidu encyclopedia-basophils
People's Network-Immunotherapy can activate neutrophils to treat cancer.